{"Ticker": "ABMD", "Company": "Abiomed", "Sector": "Health Care", "Updated": "2022-10-13", "Rating": [{"Date": "2022-10-13", "Rating": "Initiated", "Organization": "Mizuho", "Rating_Change": "Buy", "Target_Change": "$300"}, {"Date": "2022-04-06", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform", "Target_Change": "$330"}, {"Date": "2021-06-18", "Rating": "Initiated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$360"}, {"Date": "2020-04-27", "Rating": "Downgrade", "Organization": "SVB Leerink", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": "$175"}, {"Date": "2020-02-12", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Underweight", "Target_Change": "$165"}, {"Date": "2020-02-06", "Rating": "Resumed", "Organization": "BTIG Research", "Rating_Change": "Neutral", "Target_Change": ""}, {"Date": "2019-10-29", "Rating": "Downgrade", "Organization": "Raymond James", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": ""}, {"Date": "2019-08-02", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$325 to $215"}, {"Date": "2019-08-02", "Rating": "Downgrade", "Organization": "Guggenheim", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2019-08-01", "Rating": "Downgrade", "Organization": "BTIG Research", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2018-11-07", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": ""}, {"Date": "2018-11-02", "Rating": "Upgrade", "Organization": "BTIG Research", "Rating_Change": "Neutral to Buy", "Target_Change": ""}, {"Date": "2018-06-22", "Rating": "Reiterated", "Organization": "Piper Jaffray", "Rating_Change": "Overweight", "Target_Change": "$360 to $480"}, {"Date": "2018-04-04", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Buy", "Target_Change": "$332"}, {"Date": "2018-01-19", "Rating": "Reiterated", "Organization": "Leerink Partners", "Rating_Change": "Outperform", "Target_Change": "$200 to $265"}, {"Date": "2017-10-16", "Rating": "Downgrade", "Organization": "BTIG Research", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2017-09-29", "Rating": "Initiated", "Organization": "SunTrust", "Rating_Change": "Buy", "Target_Change": "$195"}, {"Date": "2017-06-08", "Rating": "Resumed", "Organization": "William Blair", "Rating_Change": "Outperform", "Target_Change": ""}, {"Date": "2017-04-06", "Rating": "Upgrade", "Organization": "Piper Jaffray", "Rating_Change": "Neutral to Overweight", "Target_Change": ""}, {"Date": "2016-12-07", "Rating": "Initiated", "Organization": "Guggenheim", "Rating_Change": "Buy", "Target_Change": ""}, {"Date": "2015-10-30", "Rating": "Upgrade", "Organization": "Raymond James", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": ""}, {"Date": "2015-08-18", "Rating": "Initiated", "Organization": "Sterne Agee CRT", "Rating_Change": "Buy", "Target_Change": "$130"}]}